PTPRC and breast cancer: EXOs released by metastatic (EO771 and 4T1) and not-metastatic (67NR) murine breast cancer cells, when intravenously administrated to mice, was predominantly distributed to the lung, which is a frequent site of metastasis for breast cancer, and were internalized by CD45+ bone-marrow-derived immune cells.